Veradigm | MDRX - Market Capitalization


Veradigm reported $520.3M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcidion AUD 118.18M 22.83M Aug/2026
Ambu A/S DKK 18.42B 15.28B Mar/2026
Amplifon EUR 2.57B 504.52M Jun/2026
Cardinal Health USD 49.72B 894M Mar/2026
Centene USD 31.35B 352M Aug/2026
Charles River Laboratories USD 7.85B 2.17B Mar/2026
Cigna USD 72.93B 2.59B Jun/2026
Coloplast 124.69B 775.88M Dec/2025
CVS Health USD 92.04B 8.7B Mar/2026
Diasorin EUR 4.02B 662.11M Aug/2026
Elevance Health USD 83.98B 19.68B Jun/2026
General Electric Aerospace USD 389.93B 93.44B Jun/2026
Gulf Medical Proj AED 1.36B 167.74M Dec/2025
Humana USD 47.69B 26.88B Jun/2026
IQVIA Holdings USD 42.66B 10.41B Aug/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Maximus USD 3.5B 1.2B Mar/2026
McKesson USD 106B 4.75B Mar/2026
Med Life RON 6.47B 243.45M Aug/2026
Molina Healthcare USD 11.92B 4.97B Jun/2026
Omnicell USD 1.89B 370M Jun/2026
Oriola-kd EUR 175.13M 37.99M Mar/2026
Owens Minor USD 217M 154M Dec/2025
Quest Diagnostics USD 23.46B 1.77B Jun/2026
Rede D'or Sao Luiz BRL 89.21B 3.75B Mar/2026
Supermax Corporation Bhd MYR 932.46M 161.22M Mar/2026
UnitedHealth USD 377.45B 131.84B Jun/2026
Veeva Systems USD 25.45B 8.07B Mar/2026
Veradigm USD 525M 621M Mar/2026